| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.004 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.009 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |